Showing 2921 - 2940 de 10239 results
Next Wednesday, June 22, a meeting will be held to recount the diseases and present the clinical trials.
Last May, three international experts carried out an audit to evaluate the Institute's human resources performance. Nearly 40 research and management1
Last year, 239 transplants were performed at the Hospital Clínic. The Donation and Transplantation Coordination Section managed 213 deceased organ do1
On Tuesday, May 31, a group of 9 journalists visited the Institute to learn about the research being carried out.
ISO 9001 Quality Management System Requirements is the nationally and internationally recognized quality standard based on continuous process improve1
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
Hospital Clínic de Barcelona chooses Aidoc’s AI to improve clinical outcomes and utilize the technology to train residents and empower them with AI e1
A study with the participation of millions of people has concluded that antidepressants do not improve the long-term quality of life of patients. Dr1
The deadline for applications is the 28th August and 2 of the 15 fellows will be hired by IDIBAPS.
The visit is part of a new communication project aimed at raising awareness of the research carried out at the Institute among patients and patient a1
The causal relationship between the TLR7 gene mutation and lupus paves the way for an effective cure
This award, worth 35,000 euros, recognises the researcher’s contribution to clinical research in diet and nutrition.
The Hospital Clínic de Barcelona, through the Maternal Foetal Medicine Service led by Dr. Francesc Figueras, has consolidated its screening programme1
Researchers from the Hospital Clínic-IDIBAPS and the CIBERSAM participate in a study that evidences the involvement of numerous genes in the developm1
Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease,1
The administration of the antibody mavrilimumab in conjunction with prednisone reduces the risk of exacerbation of symptoms of the disease and improv1
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as1
During the “PKU”liar day, held on 28 June, the latest advances in the disease were presented and workshops were organised aimed at patients and famil1
The anniversary commemoration event took place on Wednesday 29 June at the Esteve Auditorium of the Esther Koplowitz Centre. The event could als1
A weekly dose for a year and a half has been shown to reduce weight by 21% in obese people